China's Health Spending: Two Decades of Growth, Still Below OECD Norms

A Steady Climb in Health Spending

For much of the early 2000s, China devoted a relatively modest slice of its economy to health care. Over the following two decades, that share expanded consistently, reflecting deliberate policy choices: the rollout of universal basic insurance schemes, expanded rural health coverage, and sustained investment in hospital infrastructure.

By 2022, China’s health expenditure had reached 5.88% of GDP — a figure that, on its own, might seem unremarkable. But viewed against the country’s starting point and the sheer scale of the population being served, it represents a substantial reallocation of national resources.

In 2023, the share edged higher still, reaching 5.94% of GDP. The year-on-year movement from 5.88% to 5.94% is modest in percentage-point terms, but it continues a directional trend that has held for most of the past two decades.

What the Numbers Mean at Scale

Percentage-of-GDP figures can obscure as much as they reveal. China’s economy is the second largest in the world, which means even a fraction of a percentage point translates into enormous absolute sums. At the same time, the country’s population of roughly 1.4 billion people means that per-capita health spending remains far lower than the headline GDP share might suggest when compared with smaller, wealthier nations.

This tension — between aggregate spending power and per-person resource availability — sits at the heart of China’s health system challenge. Expanding coverage to rural and lower-income populations has been a stated priority for successive five-year plans, and the upward trend in the GDP share reflects genuine progress on that front.

The OECD Gap

Despite the growth trajectory, China’s 5.94% figure in 2023 remains well below the averages recorded by most high-income OECD members. Countries such as the United States, Germany, France, and Japan have long allocated between 10% and 17% of GDP to health — a gap that reflects both higher unit costs in those systems and, in many cases, older demographic profiles that drive demand.

The comparison is not straightforwardly unfavorable to China. High health spending as a share of GDP does not automatically produce better population health outcomes, as the United States example illustrates. Administrative overhead, pricing structures for pharmaceuticals, and the organization of care delivery all shape how efficiently each dollar or yuan of health spending translates into services.

Nevertheless, the gap is real and consequential. As China’s population ages — the country is projected to see a sharp rise in the share of citizens over 65 in the coming decades — pressure on health budgets will intensify. The trajectory from 5.88% in 2022 to 5.94% in 2023 suggests the system is already absorbing more resources, but the pace of increase may need to accelerate to meet future demand.

Coverage Breadth vs. Spending Depth

One of the defining features of China’s health system over the past two decades has been its emphasis on breadth of coverage over depth of benefits. The basic medical insurance schemes now cover the vast majority of the population, a remarkable administrative achievement. However, out-of-pocket costs remain significant for many households, particularly for serious or chronic illnesses that require expensive treatments or extended hospital stays.

Raising the GDP share of health spending — from the low single digits of the early 2000s toward the 5.94% recorded in 2023 — has helped reduce some of this burden. But analysts and policymakers broadly agree that further increases will be needed to bring benefit packages closer to the standards available in higher-income systems.

Looking Ahead

The data through 2023 tells a story of consistent, if unspectacular, progress. Health spending as a share of GDP has roughly doubled from where it stood two decades ago, and the 2022-to-2023 movement from 5.88% to 5.94% suggests the upward trend remains intact.

The more pressing question is whether the pace is sufficient. Demographic aging, rising chronic disease burdens, and the lingering fiscal and organizational lessons of the COVID-19 pandemic all point toward a health system that will face greater demands in the years ahead. Whether China’s health spending share converges toward OECD norms — or stabilizes at a lower level while pursuing efficiency gains — will be one of the defining domestic policy questions of the next decade.

For now, the headline figure of 5.94% of GDP in 2023 marks both how far the system has come and how much distance remains.

Source: Our World in Data. Licensed under CC BY 4.0.

Disclaimer: This post is generated from public datasets for informational purposes only and does not constitute financial, legal, medical, or professional advice. Figures reflect the source dataset as fetched on the date shown above and may have been updated since. Meridian Intelligence makes no warranty as to accuracy or fitness for a particular purpose.

Every figure above is traced to a source row. How we validate our data · Editorial standards